Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medpace Holdings, Inc.MEDP · Entity 3327 | Director | September 30, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medpace Holdings, Inc.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,861 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Exercise / conversion · Acquired 36 · Balance 27,861 F1: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 35 |
Reported balance
After 2026-09-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-30 · Exercise / conversion · Disposed 36 · Balance 35 F1: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2: On November 28, 2025, the Reporting Person was granted 143 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
F2: On November 28, 2025, the Reporting Person was granted 143 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2020 Filed May 19, 2020 20:13 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 3,858 | $0.00 Strike: $84.36 | $0.00 |
DisclosureSEC source: 0001567619-20-010758 · doc1.xml · derivative · entry 1 Carley Brian T · CIK 0001677791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,858 Underlying: Common Stock · 3,858 shares Expires 2027-05-15 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| May 17, 2019 Filed May 21, 2019 20:52 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 6,472 | $0.00 Strike: $54.99 | $0.00 |
DisclosureSEC source: 0001567619-19-011790 · doc1.xml · derivative · entry 1 Carley Brian T · CIK 0001677791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,472 Underlying: Common Stock · 6,472 shares Expires 2026-05-17 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| May 18, 2018 Filed May 22, 2018 20:04 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 8,127 | $0.00 Strike: $42.62 | $0.00 |
DisclosureSEC source: 0001140361-18-025168 · doc1.xml · derivative · entry 1 Carley Brian T · CIK 0001677791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,127 Underlying: Common Stock · 8,127 shares Expires 2025-05-18 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| May 19, 2017 Filed May 23, 2017 20:32 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 13,782 | $0.00 Strike: $26.44 | $0.00 |
DisclosureSEC source: 0001140361-17-021939 · doc1.xml · derivative · entry 1 Carley Brian T · CIK 0001677791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,782 Underlying: Common Stock · 13,782 shares Expires 2024-05-19 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.